Cellular Reactive Oxygen Species in Cancer Chemotherapy
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: closed (15 May 2024) | Viewed by 387
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer can develop anywhere in our body. Many cancers have been discovered, and attempts have been made to overcome them by researchers and medical staff around the world. One of the main therapeutic methods is chemotherapy, which uses drugs to kill cancer cells. Most chemotherapy is related to intracellular levels of reactive oxygen species (ROS). Various new therapeutic approaches also targeting intracellular ROS levels have been a focus in recent times. Understanding ROS levels in cancers during and after cancer therapy in clinical parts is important. Oxidative stress induces cancer by altering the function of proteins and dysregulating molecular signaling pathways.
We invite you to submit your recent findings or review articles to this Special Issue, which will collate current research on oxidative stress in cancer chemotherapy and antioxidants with valuable mechanisms. We welcome submissions centered around the alterations in oxidative-stress-related molecular signaling pathways during cancer chemotherapy, possible target molecules to cure cancer through oxidative stress, and the evaluation of antioxidants as drug candidates (including natural compounds) with cancer therapeutic effects. This Special Issue invites in vitro and in vivo experiments and preclinical and clinical studies highlighting the therapeutic potential of antioxidants to overcome cancer. We look forward to your contribution.
Prof. Dr. Myoung Ok Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antioxidants
- cancer
- chemotherapy
- oxidative-stress-mediated molecular mechanism
- natural compounds
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
